Filing Details
- Accession Number:
- 0001593968-20-001630
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-13 16:48:49
- Reporting Period:
- 2020-07-13
- Accepted Time:
- 2020-07-13 16:48:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1771917 | Karuna Therapeutics Inc. | KRTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1177917 | Edmund Harrigan | C/O Karuna Therapeutics, Inc. 33 Arch St Ste 3110 Boston MA 02110-1424 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-07-13 | 10,000 | $93.40 | 65,163 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Billionaire Hedge Funds
